These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20599297)

  • 1. A new bioconcentration factor model based on SMILES and indices of presence of atoms.
    Toropova AP; Toropov AA; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    Eur J Med Chem; 2010 Sep; 45(9):4399-402. PubMed ID: 20599297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified molecular input-line entry system and International Chemical Identifier in the QSAR analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Toropova AP; Toropov AA; Benfenati E; Gini G
    Chem Biol Drug Des; 2011 May; 77(5):343-60. PubMed ID: 21352501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSPR modeling bioconcentration factor (BCF) by balance of correlations.
    Toropov AA; Toropova AP; Benfenati E
    Eur J Med Chem; 2009 Jun; 44(6):2544-51. PubMed ID: 19232785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR models for toxicity of organic substances to Daphnia magna built up by using the CORAL freeware.
    Toropova AP; Toropov AA; Benfenati E; Gini G
    Chem Biol Drug Des; 2012 Mar; 79(3):332-8. PubMed ID: 22136580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. InChI-based optimal descriptors: QSAR analysis of fullerene[C60]-based HIV-1 PR inhibitors by correlation balance.
    Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
    Eur J Med Chem; 2010 Apr; 45(4):1387-94. PubMed ID: 20116899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMILES-based optimal descriptors: QSAR modeling of carcinogenicity by balance of correlations with ideal slopes.
    Toropov AA; Toropova AP; Benfenati E
    Eur J Med Chem; 2010 Sep; 45(9):3581-7. PubMed ID: 20570021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
    Toropov AA; Toropova AP; Raska I
    Eur J Med Chem; 2008 Apr; 43(4):714-40. PubMed ID: 17629592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. coral Software: QSAR for Anticancer Agents.
    Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
    Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of correlation weights of SMILES invariants for modelling oral quail toxicity.
    Toropov AA; Benfenati E
    Eur J Med Chem; 2007 May; 42(5):606-13. PubMed ID: 17218040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMILES as an alternative to the graph in QSAR modelling of bee toxicity.
    Toropov AA; Benfenati E
    Comput Biol Chem; 2007 Feb; 31(1):57-60. PubMed ID: 17275412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations.
    Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
    J Comput Chem; 2010 Jan; 31(2):381-92. PubMed ID: 19479738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved building up a model of toxicity towards Pimephales promelas by the Monte Carlo method.
    Toropova AP; Toropov AA; Raskova M; Raska I
    Environ Toxicol Pharmacol; 2016 Dec; 48():278-285. PubMed ID: 27863338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR as a random event: a case of NOAEL.
    Toropova AP; Toropov AA; Veselinović JB; Veselinović AM
    Environ Sci Pollut Res Int; 2015 Jun; 22(11):8264-71. PubMed ID: 25520208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSPR modeling of enthalpies of formation for organometallic compounds by SMART-based optimal descriptors.
    Toropov AA; Toropova AP; Benfenati E; Manganaro A
    J Comput Chem; 2009 Nov; 30(15):2576-82. PubMed ID: 19373829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CORAL: building up the model for bioconcentration factor and defining it's applicability domain.
    Toropov AA; Toropova AP; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    Eur J Med Chem; 2011 Apr; 46(4):1400-3. PubMed ID: 21295893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CORAL: QSPR model of water solubility based on local and global SMILES attributes.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jan; 90(2):877-80. PubMed ID: 22921649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation weighting of valence shells in QSAR analysis of toxicity.
    Toropov AA; Benfenati E
    Bioorg Med Chem; 2006 Jun; 14(11):3923-8. PubMed ID: 16460943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.